Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium.

Malhotra U, Zaidi AH, Kosovec JE, Kasi PM, Komatsu Y, Rotoloni CL, Davison JM, R C, Irvin, Hoppo T, Nason KS, Kelly LA, Gibson MK, Jobe BA.

PLoS One. 2013 Nov 4;8(11):e78343. doi: 10.1371/journal.pone.0078343. eCollection 2013.

2.

Optimization of photodynamic therapy response by survivin gene knockdown in human metastatic breast cancer T47D cells.

Cogno IS, Vittar NB, Lamberti MJ, Rivarola VA.

J Photochem Photobiol B. 2011 Sep 2;104(3):434-43. doi: 10.1016/j.jphotobiol.2011.05.001. Epub 2011 May 20.

PMID:
21641815
3.

Gene expression profiles in esophageal adenocarcinoma.

Dahlberg PS, Ferrin LF, Grindle SM, Nelson CM, Hoang CD, Jacobson B.

Ann Thorac Surg. 2004 Mar;77(3):1008-15.

PMID:
14992916
4.

Knockdown of PARP6 or survivin promotes cell apoptosis and inhibits cell invasion of colorectal adenocarcinoma cells.

Wang H, Li S, Luo X, Song Z, Long X, Zhu X.

Oncol Rep. 2017 Apr;37(4):2245-2251. doi: 10.3892/or.2017.5441. Epub 2017 Feb 14.

PMID:
28260087
5.

Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma.

Rosato A, Pivetta M, Parenti A, Iaderosa GA, Zoso A, Milan G, Mandruzzato S, Del Bianco P, Ruol A, Zaninotto G, Zanovello P.

Int J Cancer. 2006 Oct 1;119(7):1717-22.

6.

Down-regulation of Notch receptor signaling pathway induces caspase-dependent and caspase-independent apoptosis in lung squamous cell carcinoma cells.

Cao H, Hu Y, Wang P, Zhou J, Deng Z, Wen J.

APMIS. 2012 Jun;120(6):441-50. doi: 10.1111/j.1600-0463.2011.02825.x. Epub 2012 Apr 4.

PMID:
22583356
7.

Hyperthermia induces apoptosis by targeting Survivin in esophageal cancer.

Qin S, Xu C, Li S, Wang X, Sun X, Wang P, Zhang B, Ren H.

Oncol Rep. 2015 Nov;34(5):2656-64. doi: 10.3892/or.2015.4252. Epub 2015 Sep 8.

PMID:
26352384
8.

Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma.

Sun PL, Jin Y, Kim H, Seo AN, Jheon S, Lee CT, Chung JH.

Virchows Arch. 2013 Sep;463(3):427-36. doi: 10.1007/s00428-013-1462-9. Epub 2013 Aug 2.

PMID:
23907568
9.

Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma.

Grabowski P, Kühnel T, Mühr-Wilkenshoff F, Heine B, Stein H, Höpfner M, Germer CT, Scherübl H.

Br J Cancer. 2003 Jan 13;88(1):115-9.

10.

TGM2: a cell surface marker in esophageal adenocarcinomas.

Leicht DT, Kausar T, Wang Z, Ferrer-Torres D, Wang TD, Thomas DG, Lin J, Chang AC, Lin L, Beer DG.

J Thorac Oncol. 2014 Jun;9(6):872-81. doi: 10.1097/JTO.0000000000000229.

11.

Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.

Dong X, Lin D, Low C, Vucic EA, English JC, Yee J, Murray N, Lam WL, Ling V, Lam S, Gout PW, Wang Y.

J Thorac Oncol. 2013 Feb;8(2):161-70. doi: 10.1097/JTO.0b013e31827d5237.

12.

MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.

Zarogoulidis P, Petanidis S, Kioseoglou E, Domvri K, Anestakis D, Zarogoulidis K.

Cell Signal. 2015 Aug;27(8):1576-88. doi: 10.1016/j.cellsig.2015.04.009. Epub 2015 Apr 25.

PMID:
25917317
13.

Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome.

Kim SM, Park YY, Park ES, Cho JY, Izzo JG, Zhang D, Kim SB, Lee JH, Bhutani MS, Swisher SG, Wu X, Coombes KR, Maru D, Wang KK, Buttar NS, Ajani JA, Lee JS.

PLoS One. 2010 Nov 30;5(11):e15074. doi: 10.1371/journal.pone.0015074.

14.

OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma.

Li C, Yan Y, Ji W, Bao L, Qian H, Chen L, Wu M, Chen H, Li Z, Su C.

PLoS One. 2012;7(11):e49693. doi: 10.1371/journal.pone.0049693. Epub 2012 Nov 21.

15.

Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.

Ji ZJ, Wang JL, Chen L.

Oncol Rep. 2015 Aug;34(2):811-22. doi: 10.3892/or.2015.4062. Epub 2015 Jun 15.

PMID:
26080853
16.

Inhibition of cell proliferation and increase of chemosensitivity by simultaneous knockdown of XIAP and survivin in pancreatic carcinoma cells.

Yang J, Ouyang J, Ouyang L, Ouyang L, Chen Y.

Oncol Res. 2013;21(1):43-50. doi: 10.3727/096504013X13793555706722.

PMID:
24330851
17.

Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas.

Kim GY, Lim SJ, Kim YW.

Mod Pathol. 2011 Oct;24(10):1336-47. doi: 10.1038/modpathol.2011.90. Epub 2011 May 13.

18.

High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.

Xu C, Yamamoto-Ibusuki M, Yamamoto Y, Yamamoto S, Fujiwara S, Murakami K, Okumura Y, Yamaguchi L, Fujiki Y, Iwase H.

Breast Cancer. 2014 Jul;21(4):482-90. doi: 10.1007/s12282-012-0403-9. Epub 2012 Sep 12.

PMID:
22968628
19.
20.

High expression of survivin predicts poor prognosis in esophageal squamous cell carcinoma following radiotherapy.

Zhu H, Wang Q, Hu C, Zhang W, Quan L, Liu M, Xu N, Xiao Z.

Tumour Biol. 2011 Dec;32(6):1147-53. doi: 10.1007/s13277-011-0217-y. Epub 2011 Aug 9.

PMID:
21826474

Supplemental Content

Support Center